Initial Basal and Bolus Rates and Basal Rate Variability During Pump Treatment in Children and Adolescents

Günay Demir1, Yasemin Atik Altınok1, Samim Özen1

  • 1Ege University Faculty of Medicine, Department of Pediatrics, Division of Pediatric Endocrinology, İzmir, Turkey

Insights

Basal insulin needs in type 1 diabetes vary by age, impacting pump therapy. Adjusting basal rates based on age-specific circadian profiles optimizes treatment faster and easier for children and adolescents.

Area of Science:

  • Pediatric Endocrinology
  • Metabolic Disorders
  • Diabetes Technology

Background:

  • Type 1 diabetes (T1DM) management in children using insulin pumps shows significant variation in basal insulin (BI) needs.
  • BI requirements are influenced by age-specific patterns of cortisol and growth hormone secretion, affecting insulin sensitivity (e.g., dawn/dusk phenomena).
  • Current methods for initiating basal rates lack evidence-based recommendations, particularly for younger children, often relying on uniform distribution or tertiles.

Purpose of the Study:

  • To analyze the changes in initial, equally distributed basal insulin rates over the first year of standard insulin pump therapy in pediatric patients with T1DM.
  • To investigate the impact of age-specific circadian profiles on basal insulin requirements in young individuals with T1DM.

Main Methods:

  • A cohort of 154 patients with T1DM, aged 0 to <21 years at diagnosis, was studied retrospectively.
  • Patients were categorized into five age groups at pump initiation: <5, 5-8, 8-15, 15-18, and >18 years.
  • Hourly basal insulin rates were evaluated at pump initiation and after one year, with analysis of circadian distribution.

Main Results:

  • Mean total insulin dose/kg and mean daily basal rate/kg differed significantly across the five age groups at initiation and after one year.
  • A significant decrease in mean total insulin dose/kg was observed from initiation to one year of pump therapy (0.86±0.23 U/kg to 0.78±0.19 U/kg).
  • The circadian distribution of basal insulin varied markedly among the different age groups, highlighting age-specific needs.

Conclusions:

  • Age-specific circadian profiles are crucial considerations when initiating insulin pump therapy in pediatric patients with T1DM.
  • Accounting for these profiles can lead to faster and more effective optimization of basal insulin rates.
  • This approach supports personalized diabetes management tailored to the unique physiological characteristics of different pediatric age groups.
Abstract

Related Concept Videos

Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
424
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
109
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
107
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
109
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
90
Two-Compartment Open Model: IV Bolus Administration01:18

Two-Compartment Open Model: IV Bolus Administration

The two-compartment model for intravenous (IV) bolus administration illustrates drug distribution in the body, subdividing it into central and peripheral compartments. This model operates on the concept of two-compartment kinetics. The drug's plasma concentration shows a bi-exponential decline following IV bolus administration, signaling the presence of two disposition processes: distribution and elimination.
The disparity between drug input and the sum of drug transfer rates between...
878